Zhiguo Luo

Hubei University of Medicine - Department of Clinical Oncology

Shiyan, 442000

China

SCHOLARLY PAPERS

2

DOWNLOADS

151

SSRN CITATIONS

3

CROSSREF CITATIONS

0

Scholarly Papers (2)

1.

A Retrospective Study of 186 Patients Reveals the Strongest Immunity in the Early Two Years of Life Against Coronavirus Disease 2019

Number of pages: 36 Posted: 09 Apr 2020
Hubei University of Medicine - Department of Clinical Oncology, University of Pennsylvania - Epidemiology and Biostatistics, Hubei University of Medicine - Department of Clinical Oncology, Hubei University of Medicine - Department of Cardiology, Hubei University of Medicine - Department of Clinical Oncology, Hubei University of Medicine - Department of Clinical Oncology, Hubei University of Medicine - Department of Clinical Oncology, Hubei University of Medicine - Department of Clinical Oncology, Hubei University of Medicine - Department of Clinical Oncology, Hubei University of Medicine - Department of Clinical Oncology, Hubei University of Medicine - Department of Clinical Oncology, Hubei University of Medicine - Department of Clinical Oncology, Hubei University of Medicine - Department of Clinical Oncology, Hubei University of Medicine - Department of Clinical Oncology, Guangzhou Medical University - State Key Laboratory of Respiratory Diseases, Hubei University of Medicine - Department of Pediatrics, Hubei University of Medicine - Department of Clinical Oncology, Hubei University of Medicine - Department of Clinical Oncology, Radboud University Nijmegen - Radboud Institute for Molecular Life Sciences (RIMLS), Hubei University of Medicine - Department of Clinical Oncology and Guangzhou Medical University - State Key Laboratory of Respiratory Diseases
Downloads 119 (446,420)

Abstract:

Loading...

SARS-CoV-2; COVID-19; coronavirus; clinical feature; outcome; immunity; trained immunity; vaccine; mycoplasma; co-infection

2.

Development and Validation of an Individualized Model for Predicting COVID-19 Deterioration in Patients with Cancer: A Multicenter Retrospective Study

Number of pages: 25 Posted: 20 Jul 2020
Wuhan University - Cancer Center, Huazhong University of Science and Technology (Formerly Tongi Medical University) - Department of Orthopedic Surgery, Wuhan University - Cancer Center, Huazhong University of Science and Technology (Formerly Tongi Medical University) - Department of Oncology, Hubei Provincial Hospital of Integrated Chinese & Western Medicine - Department of Oncology, Wuhan Fifth Hospital - Department of Oncology, Yangtze University - Department of Oncology, Wuhan University - Department of Thoracic Surgery, Wuhan University of Science and Technology - Department of Respiratory and Critical Care Medicine, Hubei University of Medicine - Department of Clinical Oncology, Hubei Provincial Hospital of Traditional Chinese Medicine - Department of Oncology, Huanggang Central Hospital - Department of Oncology, People's Liberation Army - Department of Oncology, Wuhan University - Cancer Center, Wuhan University - Cancer Center, Wuhan University - Cancer Center, Wuhan University - Cancer Center, Huazhong University of Science and Technology - Department of Oncology, Wuhan University - Department of Oncology and Chinese Academy of Medical Sciences & Peking Union Medical College - State Key Laboratory of Molecular Oncology
Downloads 32 (868,414)
Citation 1

Abstract:

Loading...

Risk model; COVID-19; Deterioration; Cancer; Retrospective study